质瘤和翻译后的修改:一个复杂的关系关系
Tomasz Pienkowski1, Tomasz Kowalczyk2, Dominik Cysewski1
1Clinical Research Centre, Medical University of Bialystok, M. Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland.
Biochimica et biophysica acta. Reviews on cancer
|November 1, 2023
概括
翻译后修改 (PTMs) 改变了蛋白质的功能,并可能导致新的蛋白质形式. 了解PTM和它们在质瘤中的交叉声提供了PTMomics中的新治疗和诊断生物标志物机会.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 翻译后修饰 (PTM) 是关键的共价过程,改变了蛋白质的功能和活性.
- PTMs涉及蛋白质分解裂变或添加基,甲基,糖基或乙烯基等组到氨基酸残留物中.
- PTM交叉可以修改蛋白质的功能和结构,产生新的蛋白质形式.
研究的目的:
- 审查经过实验确认的PTM及其在质瘤中的交叉声.
- 突出PTM和蛋白质形式作为治疗点和质瘤中的生物标记物的潜力.
- 在PTMomics领域引入质瘤研究的新兴机会.
主要方法:
- 对实验证实PTM的文献综述.
- 对PTM交叉通道机制的分析.
- 专注于与质瘤相关的PTM和蛋白型.
主要成果:
- PTMs显著影响蛋白质的功能,结构和蛋白质形式的出现.
- PTM交叉声呈现出影响细胞平衡的复杂调节网络.
- 在PTM的变化与癌症的特征,包括质瘤有关.
结论:
- 编目PTM和蛋白质形式为质瘤提供了新的治疗点.
- PTM为发现疾病诊断的歧视性生物标志物提供了机会.
- PTMomics领域对促进质瘤研究和治疗具有重大前景.
更多相关视频
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.5K
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.9K
相关概念视频
Protein Glycosylation
7.0K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
7.0K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
